Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 28;17(1):40.
doi: 10.1186/s13722-022-00323-4.

Virtual opioid agonist treatment: Alberta's virtual opioid dependency program and outcomes

Nathaniel Day  1   2 , Maureen Wass  3   4 , Kelly Smith  1   2
Affiliations

Virtual opioid agonist treatment: Alberta's virtual opioid dependency program and outcomes

Nathaniel Day et al. Addict Sci Clin Pract. .

Abstract

Background: Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction requirements, employment demands and limited childcare options reduce treatment opportunities for clients. A completely virtual model of care has been developed in Alberta, Canada. This paper introduces the unique virtual clinic model and describes outcomes from that model.

Methods: A retrospective chart review was conducted using datasets within existing electronic health records and databases from Alberta's Virtual Opioid Dependency Program (VODP). Outcome data were extracted at admission to ongoing care by Case Management within the VODP and at 3, 6 and 12 months for the duration of treatment. Utilization trends over three years were analyzed, including admissions, discharges and active client information. Data regarding clinical outcomes for clients engaged in ongoing care with the VODP were aggregated for analysis over four time periods, including treatment retention rates at 6 and 12 months.

Results: A total of 440 client records were included in the study sample. Descriptive analysis showed rapid growth in utilization over three fiscal years. Despite rapid growth in utilization, median wait days for treatment decreased from 6 to 0 days with the initiation of a Same Day Start service to support low barrier immediate access to treatment. Treatment retention rates for clients in ongoing care were comparable to published reports, with 90% of the study sample remaining in treatment over 6 months, and 58% showing retention over 12 months. Clients reported high levels of satisfaction (90%) and outcomes reflected reductions in drug use and overdose as well as improved social functioning.

Conclusions: The VODP model demonstrated high levels of client satisfaction, rapid growth in utilization and positive preliminary clinical outcomes. Entirely virtual delivery of opioid agonist therapy is a promising option to facilitate access to evidence based treatment for opioid use disorder (OUD) in the context of a fentanyl overdose crisis, particularly for individuals living in rural or underserved areas.

Keywords: Low barrier; Opioid agonist therapy; Rural; Telehealth; Telemedicine; Virtual.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chat outlining steps to create study sample
See this image and copyright information in PMC

References

    1. Yang YT, Weintraub E, Haffajee RL. Telemedicine’s role in addressing the opioid epidemic. Mayo Clin Proc. 2018;93(9):1177–1180. doi: 10.1016/j.mayocp.2018.07.001. - DOI - PMC - PubMed
    1. Public Health Agency of Canada. Opioid-related Harms in Canada. Ottawa: 2020. Health-infobase.canada.ca. https://health-infobase.canada.ca/substance-related-harms/opioids. Accessed 18 Nov 2020.
    1. World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. WHO Press; 2009. https://www.who.int/publications-detail/guidelines-for-the-psychosociall.... Accessed 1 Apr 2020. - PubMed
    1. Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies–tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–6. doi: 10.1056/NEJMp1402780. - DOI - PubMed
    1. Bruneau J, Ahamad K, Goyer M, et al. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247–57. doi: 10.1503/cmaj.170958. - DOI - PMC - PubMed

MeSH terms

Substances